Journal profile · Biochemistry, Genetics and Molecular Biology-Cancer Research
Cancer Communications
ISSN 2523-3548 · Wiley · PEOPLES R CHINA · Monthly · Founded 2018
Cancer Communications: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 28.48; fully open access; APC about USD 2,800; median 145 days to acceptance (76 articles, last 24 months); 133 articles in 2025; indexed in SCIE and Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: As of January 2026, Cancer Communications is no longer published by Wiley. More information can be found on the new publisher's website: https://spj.science.org/journal/cancomm Source ↗Publisher website ·
Scope
Aims, scope and focus
Cancer Communications is published by Wiley and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies and Military Technology and Strategies, together about 30.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
<em>Cancer Communications</em> is an open access oncology journal providing a platform for collaboration on basic, clinical, and translational cancer research.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Cancer Research
Main research topics OpenAlex counts of recent articles; shares are approximate
- Legal and Regulatory AnalysisSocial Sciences10.1%
- Linguistic, Cultural, and Literary StudiesSocial Sciences10.1%
- Military Technology and StrategiesEngineering10.1%
- Head and Neck Cancer StudiesMedicine5.9%
- Cancer Immunotherapy and BiomarkersMedicine4.9%
- Lung Cancer Treatments and MutationsMedicine4.5%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.4%
- Cancer Research and TreatmentsBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 28.48LetPub ·
- CiteScore 2026-06
- 40.3LetPub ·
- SJR 2026-06
- 7.99LetPub ·
- SNIP 2026-06
- 4.89LetPub ·
- h-index
- 126OpenAlex ·
- i10-index
- 1,158OpenAlex ·
- 2-year mean citedness
- 12.83OpenAlex ·
- Self-citation rate
- 0.7%LetPub ·
- Share of gold OA articles
- 98.61%LetPub ·
Volume
- Articles per year
- 49LetPub ·
Articles by year OpenAlex count · 2,825 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 60 | 48 |
| 2025 | 133 | 133 | 981 |
| 2024 | 128 | 128 | 3,088 |
| 2023 | 131 | 131 | 3,693 |
| 2022 | 160 | 160 | 8,773 |
| 2021 | 137 | 137 | 8,859 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
145 daysMedian, submission to acceptance · P25–P75 92 days – 213 days
- Acceptance to online
- median 16 days (77 articles)
- Submission to online
- median 159 days
- Sample
- 76 articles with submission and acceptance dates (220 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 weeksLetPub ·
- Submission to publication (journal-reported)
- about 4 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,400 / GBP 2,100 / USD 2,800 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,080 / EUR 2,640 / GBP 2,310 | — | — | |
| LetPub | USD 2,800 / GBP 2,100 / EUR 2,400 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- PEOPLES R CHINA
- Language
- English
- Frequency
- Monthly
- Founded
- 2018
- ISSN
- 2523-3548
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Communications
What CAS zone is Cancer Communications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Communications is in Zone 1 of Medicine, and in Zone 1 of the minor category Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Communications?
The latest impact factor listed by LetPub is 28.48; CiteScore 40.3, h-index 126.
How long does peer review take at Cancer Communications?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 145 days (interquartile range 92–213 days); authors report an average review time of about 4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cancer Communications?
According to LetPub and DOAJ records, Cancer Communications is indexed in SCIE, Scopus and DOAJ.
Is Cancer Communications open access, and what is the APC?
Cancer Communications is a fully open-access journal. APC about USD 2,800.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .